Seattle Genetics | Egenkapital Og Reserver

Equity Capital And Reserves Endring Dato
AbbVie USD 12.09B 772M 2023-09
Acadia Pharmaceuticals USD 431.76M 69.58M 2023-12
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Bayer EUR 33.38B 3.57B 2023-09
Celldex Therapeutics USD 429.17M 182.45M 2023-12
Eisai JPY 861.67B 16.8B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
Exelixis USD 2.35B 180.32M 2023-09
Genmab DKK 31.11B 2.36B 2023-09
Gilead Sciences USD 22.75B 435M 2023-12
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Insmed USD -331923000 42.57M 2023-12
Moderna USD 13.85B 399M 2023-12
Pfizer USD 96.93B 2.08B 2023-09
Regeneron Pharmaceuticals USD 25.97B 1.07B 2023-12
Sarepta Therapeutics USD 764.36M 22.95M 2023-09
Takeda JPY 7.07T 149.3B 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
Vertex Pharmaceuticals USD 16.51B 1.04B 2023-09
Xencor USD 668.8M 214K 2023-12



Seattle Genetics Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.